Given the potential confounding effects of clinicopathologic factors, we conducted a multivariable logistic regression analysis to examine the independent association of ERBB2-low status with age, sex, race and ethnicity, Charlson-Deyo Comorbidity Index score, treatment facility type, receptor status, stage, grade, and tumor histology (Table 2). The gene discussed is ERBB2; the disease is neoplasm.